{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:55:44Z","timestamp":1781740544297,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bbrep.2026.102656","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T08:54:24Z","timestamp":1780563264000},"page":"102656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Computational identification of putative mRNA-miRNA signatures in chemoresistant and metastatic triple-negative breast cancer"],"prefix":"10.1016","volume":"46","author":[{"given":"Mahvash","family":"Farajzadeh-Dehkordi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rezvani Boroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Darzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manijeh","family":"Jalilvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102656_bib1","first-page":"10","volume":"Ca. 75","author":"Siegel","year":"2025","journal-title":"Cancer statistics"},{"key":"10.1016\/j.bbrep.2026.102656_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/his.14786","article-title":"An update on the pathological classification of breast cancer","volume":"82","author":"Rakha","year":"2023","journal-title":"Histopathology."},{"key":"10.1016\/j.bbrep.2026.102656_bib4","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/diagnostics14171875","article-title":"Triple-negative breast cancer: molecular particularities still a challenge","volume":"14","author":"Varzaru","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbrep.2026.102656_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00259-024-06866-9","article-title":"The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective","volume":"52","author":"Filippi","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.bbrep.2026.102656_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.14740\/wjon1853","article-title":"Opportunities and challenges in the development of antibody-drug conjugate for triple-negative breast cancer: the diverse choices and changing needs","volume":"15","author":"Tang","year":"2024","journal-title":"World J. Oncol."},{"key":"10.1016\/j.bbrep.2026.102656_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177202","article-title":"Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment","volume":"988","author":"Xu","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2026.102656_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217865","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): emerging therapeutic opportunities","author":"Sabit","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrep.2026.102656_bib9","first-page":"1","article-title":"Integrated analysis of bulk and single-cell transcriptomics identifies prognostic biomarkers in breast cancer metastasis","author":"Wu","year":"2025","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bbrep.2026.102656_bib10","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1007\/s10528-023-10615-2","article-title":"KNSTRN is a prognostic biomarker that is correlated with immune infiltration in breast cancer and promotes cell cycle and proliferation","volume":"62","author":"Zhang","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.bbrep.2026.102656_bib11","article-title":"Enhanced anticancer activity of nanoemulsified cardamom extract via modulation of apoptosis-and lncRNA-associated pathways in colorectal cancer cells","volume":"45","author":"Soltani","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib12","article-title":"CircRNAs: novel biomarkers and therapeutic targets for diseases of the central nervous system","volume":"45","author":"Cui","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib13","article-title":"Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: molecular mechanisms and therapeutic implications","volume":"45","author":"Das","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib14","article-title":"Investigating combined hypoxia and stemness indices for prognostic transcripts in gastric cancer: machine learning and network analysis approaches","volume":"41","author":"Mahmoudian-Hamedani","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-024-02917-y","article-title":"Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer","volume":"132","author":"Wang","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib16","article-title":"Exploration of the role of drug resistance-associated anoikis-related genes in HER2-Negative breast cancer through bioinformatics analysis","volume":"41","author":"Wu","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib17","article-title":"Integrated bioinformatics analysis identifies cuproptosis and ferroptosis gene signatures via subgroup clustering: prognostic and therapeutic implications in breast cancer","volume":"44","author":"Wei","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib18","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"V Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrep.2026.102656_bib19","doi-asserted-by":"crossref","first-page":"D730","DOI":"10.1093\/nar\/gkae1113","article-title":"The STRING database in 2025: protein networks with directionality of regulation","volume":"53","author":"Szklarczyk","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrep.2026.102656_bib20","series-title":"Data Min. Proteomics from Stand. to Appl.","first-page":"291","article-title":"Cytoscape: software for visualization and analysis of biological networks","author":"Kohl","year":"2010"},{"key":"10.1016\/j.bbrep.2026.102656_bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: an update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrep.2026.102656_bib22","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.21621","article-title":"Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells","volume":"8","author":"T\u0171zesi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2026.102656_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3892\/ol.2023.13808","article-title":"A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcoma","volume":"25","author":"Araki","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrep.2026.102656_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2021.2010959","article-title":"Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene","volume":"19","author":"Akula","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.bbrep.2026.102656_bib25","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1007\/s43032-023-01413-7","article-title":"Identification of differentially expressed mRNAs and miRNAs and related regulatory networks in cumulus oophorus complexes associated with fertilization","volume":"31","author":"Wang","year":"2024","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s11658-021-00257-w","article-title":"Molecular interactions of miR-338 during tumor progression and metastasis","volume":"26","author":"Moghbeli","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bbrep.2026.102656_bib27","first-page":"2195","article-title":"The tumor suppressor role of microRNA-338-3p in renal cell carcinoma, Oncol","volume":"16","author":"Huang","year":"2018","journal-title":"Lett"},{"key":"10.1016\/j.bbrep.2026.102656_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41419-018-0611-0","article-title":"miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2026.102656_bib29","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1111\/cas.14589","article-title":"Hypoxia\u2010inhibited miR\u2010338\u20103p suppresses breast cancer progression by directly targeting ZEB2","volume":"111","author":"He","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib30","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.2147\/OTT.S217101","article-title":"Baicalin inhibits cell viability, migration and invasion in breast cancer by regulating miR-338-3p and MORC4","author":"Duan","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrep.2026.102656_bib31","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.biopha.2018.03.075","article-title":"MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82","volume":"102","author":"Long","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrep.2026.102656_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ebiom.2019.04.010","article-title":"MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway","volume":"43","author":"Chu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbrep.2026.102656_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10863-023-09992-5","article-title":"CircDiaph3 aggravates H\/R-induced cardiomyocyte apoptosis and inflammation through miR-338-3p\/SRSF1 axis","volume":"56","author":"Lin","year":"2024","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bbrep.2026.102656_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12943-018-0915-9","article-title":"BRD4 and cancer: going beyond transcriptional regulation","volume":"17","author":"Donati","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cellimm.2019.02.001","article-title":"Emerging roles of and therapeutic strategies targeting BRD4 in cancer","volume":"337","author":"White","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.bbrep.2026.102656_bib36","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s10620-023-07907-3","article-title":"High expression level of BRD4 is associated with a poor prognosis and immune infiltration in esophageal squamous cell carcinoma","volume":"68","author":"Li","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib37","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/ijms16011928","article-title":"BRD4 inhibitor inhibits colorectal cancer growth and metastasis","volume":"16","author":"Hu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib38","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.7150\/ijbs.34162","article-title":"BRD4 inhibitor AZD5153 suppresses the proliferation of colorectal cancer cells and sensitizes the anticancer effect of PARP inhibitor","volume":"15","author":"Zhang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41418-019-0353-2","article-title":"Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail","volume":"27","author":"Lu","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrep.2026.102656_bib40","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1158\/0008-5472.CAN-16-0559","article-title":"BRD4 regulates breast cancer dissemination through Jagged1\/Notch1 signaling","volume":"76","author":"Andrieu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102656_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315163","article-title":"Bromodomain protein BRD4-mediated mutant p53 transcription promotes TNBC progression","volume":"23","author":"Zhou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib42","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.7150\/ijbs.62236","article-title":"Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer","volume":"17","author":"Ali","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102212","article-title":"BET inhibitor and CDK4\/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair","volume":"51","author":"Chi","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbrep.2026.102656_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1478-811X-10-21","article-title":"Functions of the Lyn tyrosine kinase in health and disease","volume":"10","author":"Ingley","year":"2012","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.bbrep.2026.102656_bib45","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1158\/1535-7163.MCT-08-0058","article-title":"Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma","volume":"7","author":"Guan","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.bbrep.2026.102656_bib46","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/0008-5472.CAN-03-2420","article-title":"Lyn is a target gene for prostate cancer: sequence-based inhibition induces regression of human tumor xenografts","volume":"64","author":"Goldenberg-Furmanov","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102656_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1165\/rcmb.2022-0463OC","article-title":"Enhanced Lyn activity causes severe, progressive emphysema and lung cancer","volume":"69","author":"Tsantikos","year":"2023","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrep.2026.102656_bib48","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1158\/0008-5472.CAN-12-1472","article-title":"Involvement of Lyn and the atypical kinase SgK269\/PEAK1 in a basal breast cancer signaling pathway","volume":"73","author":"Croucher","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102656_bib49","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1158\/0008-5472.CAN-10-0911","article-title":"Tyrosine phosphorylation profiling reveals the signaling network characteristics of basal breast cancer cells","volume":"70","author":"Hochgr\u00e4fe","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2026.102656_bib50","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4161\/15384047.2014.956634","article-title":"Combined inhibition of AXL, Lyn and p130Cas kinases block migration of triple negative breast cancer cells","volume":"15","author":"P\u00e9nzes","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrep.2026.102656_bib51","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1016\/j.celrep.2018.11.103","article-title":"Dual mechanisms of LYN kinase dysregulation drive aggressive behavior in breast cancer cells","volume":"25","author":"Tornillo","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrep.2026.102656_bib52","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41416-024-02875-5","article-title":"The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy","volume":"131","author":"Egeland","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3109\/03602532.2015.1047027","article-title":"Role of single nucleotide polymorphisms in pharmacogenomics and their association with human diseases","volume":"47","author":"Chaudhary","year":"2015","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbrep.2026.102656_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110069","article-title":"The emerging role of XBP1 in cancer","volume":"127","author":"Chen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrep.2026.102656_bib55","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1096\/fj.06-7990com","article-title":"Human x\u2010box binding protein\u20101 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines","volume":"21","author":"Gomez","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrep.2026.102656_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ijc.23479","article-title":"Expression and splicing of the unfolded protein response gene XBP\u20101 are significantly associated with clinical outcome of endocrine\u2010treated breast cancer","volume":"123","author":"Davies","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib57","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.5827","article-title":"A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1\/XBP1","volume":"6","author":"Ming","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrep.2026.102656_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature13119","article-title":"XBP1 promotes triple-negative breast cancer by controlling the HIF1\u03b1 pathway","volume":"508","author":"Chen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrep.2026.102656_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202133119","article-title":"Bip-Yorkie interaction determines oncogenic and tumor-suppressive roles of Ire1\/Xbp1s activation","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbrep.2026.102656_bib60","article-title":"Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.bbrep.2026.102656_bib61","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.biopha.2016.05.033","article-title":"Expression profile of plasma microRNAs in nonsyndromic cleft lip and their clinical significance as biomarkers","volume":"82","author":"Zou","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrep.2026.102656_bib62","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12933-024-02142-0","article-title":"Circulating exosomal mir-16-2-3p is associated with coronary microvascular dysfunction in diabetes through regulating the fatty acid degradation of endothelial cells","volume":"23","author":"Liu","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrep.2026.102656_bib63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1352458513496343","article-title":"Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing","volume":"20","author":"Keller","year":"2014","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.bbrep.2026.102656_bib64","first-page":"1441","article-title":"miR-16-2-3p inhibits cell proliferation and migration and induces apoptosis by targeting PDPK1 in maxillary primordium mesenchymal cells","volume":"43","author":"Han","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrep.2026.102656_bib65","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1002\/ijc.32368","article-title":"MiR\u201016\u20101\u20103p and miR\u201016\u20102\u20103p possess strong tumor suppressive and antimetastatic properties in osteosarcoma","volume":"145","author":"V Maximov","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib66","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000484620","article-title":"Regional differences in efficacy, safety, and biomarkers for second-line axitinib in patients with advanced hepatocellular carcinoma: from a randomized phase II study","volume":"7","author":"Kudo","year":"2018","journal-title":"Liver Cancer"},{"key":"10.1016\/j.bbrep.2026.102656_bib67","article-title":"Tumor-derived exosomal miRNAs as diagnostic biomarkers in non-small cell lung cancer","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:38:53Z","timestamp":1781739533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826002165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":67,"alternative-id":["S2405580826002165"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102656","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational identification of putative mRNA-miRNA signatures in chemoresistant and metastatic triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102656"}}